Targeted delivery of phytochemicals via nanocarriers: Emerging strategies for psoriasis and acne


Darbandy Z. J., Oroojalian F., Kesharwani P., KARAV S., Sahebkar A.

South African Journal of Botany, cilt.189, ss.68-85, 2026 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 189
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.sajb.2025.11.027
  • Dergi Adı: South African Journal of Botany
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Geobase
  • Sayfa Sayıları: ss.68-85
  • Anahtar Kelimeler: Acne, Herbal drug delivery, Nanocarriers, Nanoformulations, Phytoconstituents, Psoriasis
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet

Özet

Psoriasis and acne are prevalent dermatological disorders often managed with conventional therapies, which present limitations in efficacy, safety, and long-term outcomes. Recently, increasing attention has been directed toward the integration of phytoconstituents, bioactive compounds derived from medicinal plants, into nanocarrier-based drug delivery systems as a novel therapeutic strategy. Phytochemicals possess well-documented antioxidant, anti-inflammatory, and wound-healing properties, and generally offer favorable a safety profile compared to synthetic agents. Incorporated of these natural compounds into nanocarriers enhances their therapeutic potential by improving skin penetration, enabling controlled drug release, facilitating targeted delivery, and reducing dosing frequency. This review highlights recent advances in the use of nanotechnology to optimize the delivery and efficacy of phytoconstituents for treating psoriasis and acne. It also discusses the mechanistic insights, therapeutic outcomes, formulation challenges, and translational hurdles associated with the clinical application of these nano-herbal systems. Continued research and development are essential to address formulation stability, scaling processes, regulatory compliance, and clinical validation, thereby facilitating the commercialization of effective and safe phyto-nanocarrier therapies in dermatology